LLY

Lilly (Eli)

Health Care

Pharmaceuticals

Indianapolis, Indiana

Balance Sheet 35 Accounts • 5 Years

Account	2024	2023	2022	2021	2020
end	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31
Assets - CashAndCashEquivalents	$3.3B	$2.8B	$2.1B	$3.8B	$3.7B
Assets - MarketableSecuritiesCurrent	$154.8M	$109.1M	$144.8M	$90.1M	$24.2M
Assets - AccountsReceivable	$11.0B	$9.1B	$6.9B	$6.7B	$5.9B
Assets - Inventories	$7.6B	$5.8B	$4.3B	$3.9B	$4.0B
Assets - PrepaidExpensesAndOtherCurrentAssets	$8.3B	$5.5B	$2.9B	$2.5B	$2.9B
Assets - TotalCurrentAssets	$32.7B	$25.7B	$18.0B	$18.5B	$17.5B
Assets - Property,PlantAndEquipment	$17.1B	$12.9B	$10.1B	$9.0B	$8.7B
Assets - Goodwill	$5.8B	$4.9B	$4.1B	$3.9B	$3.8B
Assets - IntangibleAssets(net,ExcludingGoodwill)	$6.2B	$6.9B	$7.2B	$7.7B	$7.5B
Assets - MarketableSecuritiesNoncurrent	$3.2B	$3.1B	$2.9B	$3.2B	$3.0B
Assets - DeferredTaxAssets	$11.5B	$9.4B	$7.3B	$5.8B	$5.8B
Assets - OtherNoncurrentAssets	$5.7B	$5.0B	$4.3B	$4.1B	$3.5B
Assets - TotalNoncurrentAssets	$18.8B	$14.5B	$11.2B	$10.0B	$9.6B
Assets - TotalAssets	$78.7B	$64.0B	$49.5B	$48.8B	$46.6B
Liabilities - AccountsPayable	$3.2B	$2.6B	$1.9B	$1.7B	$1.6B
Liabilities - AccruedLiabilities	$3.4B	$2.8B	$2.1B	$1.8B	$1.8B
Liabilities - ContractLiabilitiesCurrent(deferredRevenue)	$166.3M	$193.6M	$219.2M	$262.6M	$276.8M
Liabilities - ShortTermDebtAndCurrentPortionOfLongTermDebt	$5.1B	$6.9B	$1.5B	$1.5B	$8.7M
Liabilities - OtherCurrentLiabilities	$5.1B	$3.3B	$2.8B	$3.0B	$2.8B
Liabilities - TotalCurrentLiabilities	$28.4B	$27.3B	$17.1B	$15.1B	$12.5B
Liabilities - LongTermDebt	$28.5B	$18.3B	$14.7B	$15.3B	$16.6B
Liabilities - OperatingLeaseLiabilitiesNoncurrent	$1.1B	$1.1B	$728.2M	$685.7M	$663.7M
Liabilities - DeferredTaxLiabilitiesNoncurrent	$3.5B	$4.0B	$4.6B	$5.0B	$5.1B
Liabilities - PensionAndPostretirementBenefitLiabilitiesNoncurrent	$1.3B	$1.4B	$1.3B	$2.0B	$4.1B
Liabilities - OtherNoncurrentLiabilities	$2.2B	$2.2B	$1.8B	$1.6B	$1.7B
Equity - PreferredStock	$5.0M	$5.0M	$5.0M	$5.0M	$5.0M
Equity - CommonStock	$592.4M	$593.6M	$594.1M	$596.3M	$598.2M
Equity - AdditionalPaidInCapital	$7.4B	$7.3B	$6.9B	$6.8B	$6.8B
Equity - RetainedEarnings(deficit)	$13.5B	$10.3B	$10.0B	$9.0B	$7.8B
Equity - TreasuryStock	$2.5B	$750.0M	$1.5B	$52.7M	$55.7M
Equity - AccumulatedOtherComprehensiveIncome(loss)	$-4.3B	$-4.3B	$-3.8B	$-4.3B	$-6.5B
Equity - NoncontrollingInterest(permanentEquity)	$79.5M	$91.8M	$125.6M	$175.6M	$183.6M
Equity - TotalStockholdersEquity	$14.2B	$10.8B	$10.6B	$9.0B	$5.6B
Equity - TotalLiabilitiesAndStockholdersEquity	$78.7B	$64.0B	$49.5B	$48.8B	$46.6B

Income Statement 19 Accounts • 5 Years

Account	2024	2023	2022	2021	2020
end	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31
IncomeStatement - Revenues - NetProductSales/Revenues	$45.0B	$34.1B	$28.5B	$28.3B	$24.5B
IncomeStatement - CostsAndExpenses - CostOfGoodsSold	$8.4B	$7.1B	$6.6B	$7.3B	$5.5B
IncomeStatement - CostsAndExpenses - Selling,GeneralAndAdministrative(andMarketing)	$8.6B	$7.4B	$6.4B	$6.4B	$6.1B
IncomeStatement - CostsAndExpenses - AmortizationOfIntangibleAssets(operating)	$552.9M	$505.6M	$579.7M	$628.8M	$428.2M
IncomeStatement - CostsAndExpenses - Depreciation(operating)	$1.1B	$901.9M	$816.6M	$787.0M	$765.2M
IncomeStatement - CostsAndExpenses - RestructuringAndImpairmentCharges	$860.6M	$67.7M	$244.6M	$316.1M	$131.2M
IncomeStatement - OtherIncomeExpense - InterestIncome	$175.2M	$173.6M	$62.8M	$25.4M	$33.0M
IncomeStatement - OtherIncomeExpense - Gain(loss)OnInvestments/EquityMethod	$-49.8M	$-23.5M	$-420.0M	$178.0M	$1.4B
IncomeStatement - OtherIncomeExpense - OtherNonoperatingIncome(expense)	$-25.4M	$-32.7M	$-14.3M	$51.4M	$-195.5M
IncomeStatement - OtherIncomeExpense - Income(loss)FromContinuingOperationsBeforeIncomeTaxes	$12.7B	$6.6B	$6.8B	$6.2B	$7.2B
IncomeStatement - IncomeTax - IncomeTaxExpense(benefit)	$2.1B	$1.3B	$561.6M	$573.8M	$1.0B
IncomeStatement - NetIncomeAndEps - NetIncome(loss)	$10.6B	$5.2B	$6.2B	$5.6B	$6.2B
IncomeStatement - NetIncomeAndEps - NetIncome(loss)AttributableToCompany	$10.6B	$5.2B	$6.2B	$5.6B	$6.2B
IncomeStatement - NetIncomeAndEps - BasicEarningsPerShare	$12	$6	$7	$6	$7
IncomeStatement - NetIncomeAndEps - DilutedEarningsPerShare	$12	$6	$7	$6	$7
IncomeStatement - NetIncomeAndEps - WeightedAverageSharesOutstandingBasic	$900.6M	$900.2M	$901.7M	$907.0M	$907.6M
IncomeStatement - NetIncomeAndEps - WeightedAverageSharesOutstandingDiluted	$904.1M	$903.3M	$904.6M	$911.7M	$912.5M
IncomeStatement - NetIncomeAndEps - ComprehensiveIncome(loss)	$10.6B	$4.8B	$6.7B	$7.7B	$6.2B

Cash Flow Statement 25 Accounts • 5 Years

Account	2024	2023	2022	2021	2020
end	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31
CashFlow - OperatingActivities - NetIncome	$10.6B	$5.2B	$6.2B	$5.6B	$6.2B
CashFlow - OperatingActivities - DepreciationAndAmortization	$1.8B	$1.5B	$1.5B	$1.5B	$1.3B
CashFlow - OperatingActivities - ShareBasedCompensation	$645.6M	$628.5M	$371.1M	$342.8M	$308.1M
CashFlow - OperatingActivities - DeferredIncomeTaxes	$-2.7B	$-2.3B	$-2.2B	$-802.3M	$-134.5M
CashFlow - OperatingActivities - Gain/lossOnSale/disposalOfAssets/businesses(nonCashAdj.)	$-49.8M	$-23.5M	$-420.0M	$178.0M	$1.4B
CashFlow - OperatingActivities - ChangesInOperatingAssetsAndLiabilities	$4.7B	$7.3B	$2.0B	$-360.9M	$2.7B
CashFlow - OperatingActivities - NetCashFromOperatingActivities(continuingOperations)	$8.8B	$4.2B	$7.6B	$7.4B	$6.5B
CashFlow - InvestingActivities - CapitalExpenditures(pp&e&Intangibles)	$5.1B	$3.4B	$1.9B	$1.3B	$1.4B
CashFlow - InvestingActivities - PurchasesOfMarketableSecurities/investments	$98.5M	$98.2M	$107.4M	$83.5M	$11.4M
CashFlow - InvestingActivities - ProceedsFromSales/maturitiesOfMarketableSecurities/investments	$148.9M	$192.2M	$121.4M	$47.4M	$129.7M
CashFlow - InvestingActivities - PaymentsForInProcessR&d	$3.3B	$3.9B	$1.1B	$668.6M	—
CashFlow - InvestingActivities - OtherInvestingActivities	$298.2M	$191.9M	$302.2M	$191.7M	$-102.8M
CashFlow - InvestingActivities - NetCashFromInvestingActivities(continuingOperations)	$-9.3B	$-7.2B	$-3.8B	$-2.9B	$-2.3B
CashFlow - FinancingActivities - ProceedsFromIssuanceOfDebt	$11.4B	$4.0B	$0	$2.4B	$2.1B
CashFlow - FinancingActivities - RepaymentsOfDebt	$664.2M	$0	$1.6B	$1.9B	$276.5M
CashFlow - FinancingActivities - PaymentsForRepurchaseOfCommonStock	$2.5B	$750.0M	$1.5B	$1.2B	$500.0M
CashFlow - FinancingActivities - PaymentOfDividends	$4.7B	$4.1B	$3.5B	$3.1B	$2.7B
CashFlow - FinancingActivities - OtherFinancingActivities	$-490.6M	$-335.0M	$-308.9M	$-295.9M	$-241.6M
CashFlow - FinancingActivities - NetCashFromFinancingActivities(continuingOperations)	$1.2B	$3.5B	$-5.4B	$-4.1B	$-3.1B
CashFlow - CashReconciliationAndSupplemental - EffectOfExchangeRateChangesOnCash	$-296.7M	$168.6M	$-167.6M	$-205.7M	$216.0M
CashFlow - CashReconciliationAndSupplemental - NetChangeInCash	$449.8M	$751.6M	$-1.8B	$161.4M	$1.3B
CashFlow - CashReconciliationAndSupplemental - IncomeTaxesPaid	$6.6B	$5.6B	$2.7B	$1.6B	$954.6M
CashFlow - CashReconciliationAndSupplemental - InterestPaid	$577.5M	$404.2M	$323.7M	$338.0M	$345.8M
CashFlow - CashReconciliationAndSupplemental - RightOfUseAssetsObtainedForLeases(nonCash)	$210.0M	$590.0M	$155.4M	$163.5M	$136.7M

Lilly (Eli)

Balance Sheet 35 Accounts • 5 Years

Income Statement 19 Accounts • 5 Years

Cash Flow Statement 25 Accounts • 5 Years

Stock Market Data (1 Year) Live Yahoo Finance Data

Recent Price History